Total Payments
$14,402
2024 Payments
$5,765
Companies
34
Transactions
244
Medicare Patients
7,337
Medicare Billing
$672,710
Payment Breakdown by Category
Food & Beverage$7,775 (54.0%)
Travel$6,237 (43.3%)
Other$252.27 (1.8%)
Education$137.57 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,775 | 224 | 54.0% |
| Travel and Lodging | $6,237 | 16 | 43.3% |
| Grant | $202.27 | 1 | 1.4% |
| Education | $137.57 | 2 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Penumbra, Inc. | $3,637 | 7 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $1,631 | 12 | $0 (2024) |
| Boston Scientific Corporation | $1,028 | 9 | $0 (2023) |
| Cook Incorporated | $946.15 | 3 | $0 (2024) |
| Inari Medical, Inc. | $905.03 | 4 | $0 (2023) |
| Abbott Laboratories | $831.16 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $732.25 | 46 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $652.10 | 32 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $513.72 | 21 | $0 (2024) |
| ABIOMED | $411.28 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,765 | 44 | Penumbra, Inc. ($2,471) |
| 2023 | $1,981 | 31 | Inari Medical, Inc. ($905.03) |
| 2022 | $2,389 | 25 | Penumbra, Inc. ($1,167) |
| 2021 | $1,758 | 40 | BOSTON SCIENTIFIC CORPORATION ($290.83) |
| 2020 | $887.15 | 41 | Boehringer Ingelheim Pharmaceuticals, Inc. ($171.44) |
| 2019 | $887.40 | 47 | Boehringer Ingelheim Pharmaceuticals, Inc. ($182.86) |
| 2018 | $231.84 | 11 | Regeneron Healthcare Solutions, Inc. ($88.77) |
| 2017 | $502.94 | 5 | Abbott Laboratories ($432.52) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Penumbra, Inc. | RUBY Coil (Device) | Travel and Lodging | Cash or cash equivalent | $377.11 | General |
| Category: Peripheral Intervention | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: Cardiovascular | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Cardiology | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $36.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Heart Failure | ||||||
| 04/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/08/2024 | Bard Peripheral Vascular, Inc. | — | Travel and Lodging | In-kind items and services | $308.65 | General |
| 04/08/2024 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $47.77 | General |
| 04/04/2024 | Cook Incorporated | COOK CELECT (Device) | Travel and Lodging | Cash or cash equivalent | $696.63 | General |
| Category: Peripheral Intervention | ||||||
| 04/04/2024 | Cook Incorporated | COOK CELECT (Device) | Travel and Lodging | Cash or cash equivalent | $142.79 | General |
| Category: Peripheral Intervention | ||||||
| 04/04/2024 | Cook Incorporated | COOK CELECT (Device) | Food and Beverage | Cash or cash equivalent | $106.73 | General |
| Category: Peripheral Intervention | ||||||
| 04/01/2024 | Bard Peripheral Vascular, Inc. | — | Travel and Lodging | In-kind items and services | $237.99 | General |
| 03/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Not Applicable | ||||||
| 03/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $26.07 | General |
| Category: Heart Failure and Hypertension | ||||||
| 03/18/2024 | Cook Medical LLC | COOK CELECT (Device) | Travel and Lodging | Cash or cash equivalent | $350.72 | General |
| Category: Peripheral Intervention | ||||||
| 03/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,557 | 3,352 | $450,082 | $149,693 |
| 2022 | 16 | 962 | 1,260 | $132,677 | $50,432 |
| 2021 | 12 | 1,217 | 1,712 | $535,679 | $134,023 |
| 2020 | 17 | 2,601 | 4,120 | $1.3M | $338,562 |
Total Patients
7,337
Total Services
10,444
Medicare Billing
$672,710
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 219 | $54,750 | $19,957 | 36.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 125 | 132 | $46,992 | $16,874 | 35.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 132 | 242 | $34,066 | $14,557 | 42.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 266 | 272 | $37,536 | $12,734 | 33.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 70 | 74 | $43,151 | $12,170 | 28.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 23 | 28 | $39,200 | $11,168 | 28.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 29 | 65 | $32,150 | $10,500 | 32.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 837 | 1,331 | $23,958 | $8,145 | 34.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 62 | 81 | $15,707 | $7,270 | 46.3% |
| 92941 | Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | Facility | 2023 | 12 | 12 | $16,392 | $5,625 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 44 | $14,960 | $5,286 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $17,280 | $5,071 | 29.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 83 | 83 | $14,268 | $4,294 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $11,622 | $3,951 | 34.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 30 | 33 | $6,105 | $2,260 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $4,320 | $1,349 | 31.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 82 | 82 | $3,608 | $1,185 | 32.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 103 | 127 | $10,645 | $1,177 | 11.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 108 | 115 | $4,715 | $1,056 | 22.4% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 18 | 18 | $5,292 | $918.75 | 17.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $2,592 | $913.73 | 35.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 82 | 82 | $2,542 | $794.98 | 31.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 39 | 40 | $1,840 | $724.66 | 39.4% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 40 | 41 | $2,460 | $704.90 | 28.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 13 | $1,108 | $488.02 | 44.0% |
About Kamel Sadat
Kamel Sadat is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013189281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kamel Sadat has received a total of $14,402 in payments from pharmaceutical and medical device companies, with $5,765 received in 2024. These payments were reported across 244 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,775).
As a Medicare-enrolled provider, Sadat has provided services to 7,337 Medicare beneficiaries, totaling 10,444 services with total Medicare billing of $672,710. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Chicago, IL
- Active Since 03/28/2008
- Last Updated 07/08/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1013189281
Products in Payments
- RUBY Coil (Device) $2,329
- Indigo System (Device) $1,308
- COOK CELECT (Device) $1,297
- CT THROMBECTOMY SYSTEM KIT (Device) $905.03
- LifeVest (Device) $652.10
- Crosser iQ (Device) $602.53
- ENTRESTO (Drug) $547.59
- XARELTO (Drug) $513.72
- Impella (Device) $411.28
- RotarexS 6 F x 135 cm (Device) $367.97
- WATCHMAN FLX (Device) $260.52
- GORE CARDIOFORM Septal Occluder (Device) $254.09
- WATCHMAN Access System (Device) $219.59
- JARDIANCE (Drug) $214.49
- Diamondback Coronary (Device) $203.49
- PCI Optimization (Device) $202.71
- GENERAL CATHETER (Device) $202.27
- LEQVIO (Drug) $169.91
- PRADAXA (Drug) $165.96
- ELIQUIS (Drug) $163.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Myles Wolf, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Robert Kushner, Md, MD
Internal Medicine — Payments: $549,886
Internal Medicine $549,886
Dr. Adam Stein, M.d, M.D
Internal Medicine — Payments: $503,325
Internal Medicine $503,325
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247
Internal Medicine $501,247